Filters
Product Type
- 97
General
Inflammatory Bowel Diseases
Inflammatory Bowel Diseases
Tracks
- 90
- 3
- 3
Speakers
Newest
Showing results 1 - 20 of 97
DateMay 21, 2024SOCIETY: AGA This session examines one of the hot topic in IBD researchModerators
Icahn School of Medicine at Mount SinaiDartmouth-Hitchcock
DateMay 21, 2024SOCIETY: AGAModerators
Yale School of MedicineCase Western Reserve University School of Medicine
DateMay 21, 2024LIVE STREAM SESSION This annual session will provide DDW attendees the opportunity to hear opposing viewpoints from leading GI experts on the most challenging issues in clinical gastroenterology and hepatology, in a debate format…Moderators
University of Virginia Health SystemMayo Clinic in Florida
DateMay 21, 2024SOCIETY: AGA In this session, several clinically relevant presentations will put the attendee at the cutting edge of research and clinical care, with regard to stem cells for perinal fistulas, biologic de-escalation, subcutaneous biologics, and use of small molecules in microscopic colitisModerators
Massachusetts General HospitalUniversity of Wisconsin
DateMay 21, 2024SOCIETY: AGA Progress in understanding how the stromal cells in the intestine take part in forming the villus crypt axis. Also how abnormalilties in the niche lead to disease…Moderators
Johns Hopkins UniversityDana Farber Cancer Institute
DateMay 21, 2024SOCIETY: DDWModerators
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center
DateMay 21, 2024SOCIETY: AGA As our scientific tools improve, so does our ability to link the environment with different aspects of IBD…Moderators
University of ManitobaWashington University School of Medicine in St. Louis
DateMay 21, 2024SOCIETY: AGAModerators
Univ of Illinois at ChicagoUniversity of California Riverside
DateMay 21, 2024SOCIETY: AGA This session is the second session of the ever-popular and clinically impactful clinical trials sessions in IBD. Insights into novel agents including obefazimod, VTX002. MH002, risankizumab, and mirikizumab will be presented…Moderators
Cleveland ClinicUNC Chapel Hill
DateMay 20, 2024SOCIETY: AGA Natural products obtained from diet or microbial derived metabolites are increasingly gaining attention for their potential therapeutic potential in gastro-intestinal disorders…Moderators
Univ of Illinois at ChicagoUniversity of Colorado
DateMay 20, 2024SOCIETY: AGAModerators
University of PennsylvaniaCedars-Sinai Medical Center
DateMay 20, 2024SOCIETY: AGAModerators
Cincinnati Children's Hospital Medical CenterImperial College London Faculty of Medicine
DateMay 20, 2024SOCIETY: AGA This symposium focuses on frustrating scenarios where histopathologic examination of inflammatory gastrointestinal tract biopsies shows findings that do not match a patient's clinical scenario or provide a challenging differential diagnosis…Moderator
Emory University
DateMay 20, 2024SOCIETY: AGA The AGA-FDA Town Hall provides health care professionals, clinical trial investigators, and other interested stakeholders an opportunity to hear directly from FDA representatives about the agency's thinking behind recent approvals, safety signals, guidance documents, and boxed warnings…Moderators
Middleburg ConsultantsUniversity of Tennessee Health Science Center
DateMay 20, 2024SOCIETY: AGA This session highlights the best of the best in basic and clinical science research submitted to DDW 2024…Moderators
ucsfMassachusetts General Hospital
DateMay 20, 2024SOCIETY: AGA Small molecules are a new exicting therapeutic class in IBD that may have potential safety signals which have not been well described in the real world…Moderators
University of California Los AngelesMayo Clinic Arizona
DateMay 20, 2024SOCIETY: ASGEModerators
Johns Hopkins University School of MedicineThe Ohio State University Wexner Medical Center
DateMay 20, 2024SOCIETY: AGA Clinical guidelines increasingly rely on technical reviews of evidence and these in turn are becoming increasingly complex in methods. This offers great promise to truly achieve evidence based clinical guidelines…Moderators
University of Central Lancashire, UKMcMaster University
DateMay 20, 2024SOCIETY: AGA This session will explore the complex dynamics between the gut microbiome and immune checkpoint inhibitors, addressing whether specific microbes/metabolites enhance therapeutic outcomes acting as allies or present challenges as potential foes, impacting treatment efficacy and associate…Moderators
Mayo ClinicStanford University
DateMay 20, 2024SOCIETY: AGA This session will provide an insight into the critical, but less commonly studied cells potentially implicated in the pathogenesis of IBD…Moderators
Stanford University School of MedicineUniversity of California, San Francisco
